ALL NEWS TODAY

[ ALL NEWS TODAY ]

New Human H5N1 Bird Flu Vaccine From Baxter Shows Promise In Trial

Results of a phase I and phase II trial on a new human vaccine against the deadly H5N1 bird flu virus that is made from cell culture instead of embryonated eggs (making it faster and cheaper to produce) show that it is safe and effective against a number of divergent strains.

Children With Down Syndrome Sleep Poorly And Have More Fragmented Sleep

Children with Down Syndrome sleep poorly, with more fragmented sleep and frequent awakenings compared to typically developing children, according to a research abstract presented on Tuesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).

The World Medical Markets Fact Book 2008

Research and Markets has announced the addition of the "The World Medical Markets Fact Book 2008" report to their offering. The need to understand world medical markets, and be able to answer quickly those questions that arise daily, is essential. Therefore an authoritative, current and comprehensive market intelligence source is an invaluable aid for every executive.

American Association For Homecare Sues U.S. Department Of Health And Human Services To Halt Controversial Bidding Program Scheduled To Start July 1

Citing faulty implementation of Medicare's competitive bidding program for durable medical equipment, prosthetics, and supplies (DMEPOS), the American Association for Homecare filed a federal lawsuit on June 9 seeking to stop the controversial bidding program.

Growing Awareness Of High Blood Pressure Driving The European Market For Non-Invasive Blood Pressure Monitoring

The European market for non-invasive blood pressure monitoring is witnessing steady growth as a result of improving awareness about the health risks of high blood pressure. There is now a greater acknowledgement of the need to be vigilant against abnormal blood pressure levels, increasing the practice of self monitoring among the general public.

New Potential Application For Suba-Itraconazolea In Oncology - Improved Anti-fungal Drug Targets Oncology Market

HalcyGen Pharmaceuticals Limited (ASX: HGN) can confirm that itraconazole, the active ingredient in HalcyGen's lead drug SUBA-Itraconazole~A, is a potent inhibitor of the proliferation of endothelial cells. These are the key cells involved in tumour-angiogenesis and related growth of tumours.

Tea And Heart Health

"Drinking more than three cups of tea a day cuts the risk of a heart attack", The Daily Telegraph reported. The newspaper said that according to research, tea - with or without milk - may also strengthen bones. It adds that the "beneficial effects on many biochemical effects in the body" are due to polyphenols, which are natural plant antioxidants in tea.

Bristol-Myers Squibb And Pfizer Initiate New Study In The Apixaban Phase 3 Clinical Trial Program

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) announced the start of a new Phase 3 clinical trial to assess the effect of apixaban in patients with venous thromboembolism (VTE), a potentially fatal disease process that begins with blood clots in the leg veins or lungs.

Vaccine Resistant Meningitis C

The Daily Express reported that "hundreds of thousands of children may need booster injections against meningitis after the discovery of three new "superbug" strains of the disease". It says that the meningitis vaccine, previously thought to be 100% effective, is "powerless against the highly evolved strains".

Specific Immune Therapy Works For Many People And It Is Becoming Increasingly Popular In Europe

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies. When it is green and the flowers have returned, the allergy season has hit its peak.

Rocket: [100] [200]
ALL NEWS TODAY © PoznaiSebya.Сom
Designer Dmytriev Dmytriy